Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
The cells from tumor tissue were stained with anti-CD3-PE, anti-CD4-APC, and anti-CD8-FITC antibodies for 30 min, and further analyzed the ratio of different types T cells by flow cytometry
Loss of TGH/Ces3 in mice decreases blood lipids, improves glucose tolerance, and increases energy expenditure
Hellinger R, Sigurdsson A, Wu W, Romanova EV, Li L, Sweedler JV
You may be asking why
Eder P, Zielinska A, Karczewski J et al (2021) How could nanobiotechnology improve treatment outcomes of anti-TNF-alpha therapy in inflammatory bowel disease
48 OlliaroP.MussanoP
US$ 23.32
US$ 21.47
.jpg&quality=&newwidth=540)
US$ 21.17
US$ 27.69
